Thank you for your kind words. Here's that interview with CEO Darryl Davies I mentioned on another thread.
It's pretty dry but a solid and up-to-date summary of where the company's at.
If it's too long, scroll forward to the 24 minute and 25 second mark. This is where the Q & A starts.
He gets asked a fair few pertinent questions re funding, competition, patents, M & A talks, and the key difference between synthetic opioids vs synthetic THC.
InhaleRx (ASX:IRX) | Webinar with Darryl Davies | 25/07/24 - YouTube
GLTAH
THE BUY CASE, page-24
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
